Tsubata T, Wakabayashi C and Adachi T. Regulation of B cell antigen receptor signaling by CD72. In Activating and Inhibitory Immunoglobulin-like Receptors (ed. by Max D. Cooper, Toshiyuki Takai, and Jeffrey V. Ravetch) Sprnger-Verlag Tokyo p.123-128 (2001)
Wakabayashi C, Kunugi H. Involvement of IL-6 and GSK3β in impaired sensorimotor gating induced by high-fat diet. Neurosci Res 147:33-38 (2019)
Hidese H, Ota M, Wakabayashi C, Noda T, Ozawa H, Okubo T, Kunugi H. Effects of chronic l-theanine administration in patients with major depressive disorder: an open-label study. Acta Neuropsychiatr 29:72-79 (2017)
Wakabayashi C, Numakawa T, Ooshima Y, Hattori K, Kunugi H. Possible role of the dopamine D1 receptor in the sensorimotor gating deficits induced by high-fat diet. Psychopharmacology (Berl) 232:4393-4400 (2015)
Wakabayashi C, Numakawa T, Odaka H, Ooshima Y, Kiyama Y, Manabe T, Kunugi H, Iwakura Y. IL-1 receptor-antagonist (IL-1Ra) knockout mice show anxiety-like behavior by aging. Neurosci Lett 599:20-25 (2015)
Ota M, Wakabayashi C, Sato N, Hori H, Hattori K, Teraishi T, Ozawa H, Okubo T, Kunugi H. Effect of L-theanine on glutamatergic function in patients with schizophrenia. Acta Neuropsychiatr 27:291-296 (2015)
Ota M, Ogawa M, Kato K, Wakabayashi C, Kunugi H. Methamphetamine-sensitized rats show augmented dopamine release to methylphenidate stimulation: A positron emission tomography using [18F]fallypride. Psychiatry Res 232:92-97 (2015)
Ota M, Wakabayashi C, Matsuo J, Kinoshita Y, Hori H, Hattori K, Sasayama D, Teraishi T, Obu S, Ozawa H, Kunugi H. Effect of L-theanine on sensorimotor gating in healthy human subjects. Psychiatry Clin Neurosci 68:337-343 (2014)
Richards M, Chiba S, Ninomiya M, Wakabayashi C, Kunugi H. Inhibition of olanzapine-induced weight gain by the retinoid analog AM-80. Pharmacopsychiatry 46:267-273 (2013)
Xu M, Hou R, Sato-Hayashizaki A, Man R, Zhu C, Wakabayashi C, Hirose S, Adachi T, Tsubata T. Cd72c is a modifier gene that regulates Faslpr-induced autoimmune disease. J Immunol 190:5436-5445 (2013)
Sasayama D, Hattori K, Wakabayashi C, Teraishi T, Hori H, Ota M, Yoshida S, Arima K, Higuchi T, Amano N, Kunugi H. Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder. J Psychiatr Res 47:401-406 (2013)
Chiba S, Numakawa T, Richards M, Wakabayashi C, Kunugi H. Chronic restraint stress causes anxiety- and depression-like behaviors, downregulates glucocorticoid receptor expression, and attenuates glutamate release induced by brain-derived neurotrophic factor in the prefrontal cortex. Prog Neuro-Psychopharmacol Biol Psychiatry 39:112-119 (2012)
Wakabayashi C, Numakawa T, Ninomiya M, Chiba S, Kunugi H. Behavioral and molecular evidence for psychotropic effects in L-theanine. Psychopharmacology 219:1099-1109 (2012)
Wakabayashi C, Kiyama Y, Kunugi H, Manabe T, Iwakura Y. Age-dependent regulation of depression-like behaviors through modulation of adrenergic receptor α1A subtype expression revealed by the analysis of IL-1Ra knockout mice. Neuroscience 192:475-484 (2011)
Sasayama D*, Wakabayashi C*, Hori H, Teraishi T, Hattori K, Ota M, Ishikawa M, Arima K, Higuchi T, Amano N, Kunugi H. Association of plasma IL-6 and soluble IL-6 receptor levels with the Asp358Ala polymorphism of the IL-6 receptor gene in schizophrenic patients. J Psychiat Res 45:1439-1444 (2011)(*equal contribution)
Hattori K, Tanaka H, Wakabayashi C, Yamamoto N, Uchiyama H, Teraishi T, Hori H, Arima K, Kunugi H. Expression of Ca2+-dependent activator protein for secretion 2 is increased in the brains of schizophrenic patients. Prog Neuro-Psychopharmacol Biol Psychiatry 35:1738-1743 (2011)
Wakabayashi C*, Adachi T*, Wienands J, Tsubata T. A distinct signaling pathway used by the IgG-containing B cell antigen receptor. Science 298:2392-2395 (2002)(*equal contribution)
Adachi T, Wakabayashi C, Nakayama T, Yakura H, Tsubata T. CD72 negatively regulates signaling through the antigen receptor of B cells. J Immunol 164:1223-1229 (2000)
Adachi T, Wienands J, Wakabayashi C, Yakura H, Reth M, Tsubata T. SHP-1 requires inhibitory co-receptors to down-modulate B cell antigen receptor-mediated phosphorylation of cellular substrates. J Biol Chem 276:26648-26655 (2001)
Hasegawa H, Suzuki R, Wakabayashi C, Murata J, Tezuka Y, Saiki I, Kadota S. Synthesis of a biologically active fluorescent derivative of GM1, a main Ginseng saponin metabolite formed by intestinal bacteria. Biol Pharm Bull 21:513-516 (1998)
Wakabayashi C, Murakami K, Hasegawa H, Murata J, Saiki I. An intestinal bacterial metabolite of ginseng protopanaxadiol saponins has the ability to induce apoptosis in tumor cells. Biochem Biophys Res Commun 246:725-730 (1998)
Wakabayashi C, Hasegawa H, Murata J, Saiki I. Panax ginseng, ginsenosides,intestinal bacterial metabolites,metastasis,tumor invasion.J Trad Med 14:180-185 (1997)
Wakabayashi C, Hasegawa H, Murata J, Saiki I. In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration. Oncol Res 9:411-417 (1997)
口頭発表・ポスター
講演
Wakabayashi C. Possible involvement of low-grade systemic inflammation in sensorimotor gating deficits: a study of a ‘schizophrenia-like’ mouse model. The 54th WPS-IIIS seminar (Tsukuba) Feb.25 (2015)
Wakabayashi C, Numakawa T, Ooshima Y, Hattori K, Kunugi H. Possible role of the dopamine D1 receptor in the sensorimotor gating deficits induced by high-fat diet. Neuroscience 2015 (Chicago, IL, USA) Oct. 21 (2015)
Wakabayashi C, Kunugi H. A role of IL-17A on the deficit of sensorimotor gating in high-fat diet fed mice Neuro2015 (Kobe, Japan) July. 28 (2015)
Wakabayashi C, Numakawa T, Ooshima Y, Hattori K, Kunugi H. High fat diet-induced deficiency of prepulse inhibition in mice. Neuro2014(Yokohama, Japan)Sep. 12 (2014)
Wakabayashi C, Hattori K, Sasayama D, Higuchi T, Kunugi H. Increased cerebrospinal fluid vascular endothelial growth factor levels in patients with major depressive disorder. Neuro2013 (Kyoto, Japan) June. 21 2013
Wakabayashi C, Numakawa T, Kiyama Y, Manabe T, Kunugi H, Iwakura Y. Analysis of Behavioral phenotype observed in IL-1Ra KO after chronic mild immobilization stress. The 11th biennial Meeting of the Asian Pacific Society for Neurochemistry (Kobe, Japan) Oct. 1 (2012)
Chiba S, Numakawa T, Ninomiya M, Richards MC, Wakabayashi C, Himi T, Kunugi H. Changes in emotional behaviors and the action of brain-derived neurotrophic factor in the prefrontal cortex after exposure to chronic restraint stress. 第54回日本神経化学会大会(石川)2011年9月26日
Wakabayashi C, Numakawa T, Ninomiya M, Chiba S, Kunugi H. Behavioral and molecular evidence for psychotropic effects in L-theanine. Neuro2011 (Yokohama, Japan) Sep. 15 (2011)
Wakabayashi C, Sasayama D, Kunugi H. Analysis of plasma cytokine level and cytokine-related genetic polymorphism in schizophrenia. Neuro2010(Kobe, Japan)Sep. 3 (2010)
Wakabayashi C, Iwakura Y. Analysis of stress sensitivity observed in IL-1 receptor antagonist (IL-1ra) KO mice. Neuro 2009 (Nagoya, Japan) Sep.17 (2009)
Wakabayashi C, Iwakura Y. IL-1 Receptor Antagonist (IL-1Ra) KO mice Shows behavioral abnormalities. A Brain Research Meeting: Stress Coping & Disease (Arlington, VA, USA) Nov.13 (2008)
Wakabayashi C, Iwakura Y. The mechanisms of the stress-induced behavioral abnormality in the IL-1 receptor antagonist (IL-1Ra) KO mice. Neuro 2008 (Tokyo, Japan) July. 10 (2008)
Wakabayashi C, Iwakura Y. IL-1 receptor antagonist (IL-1Ra) KO mice show anxiety-like behaviour. Neuro 2007(Yokohama, Japan)Sep. 11 (2007)